Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166009 · ClinicalTrials.gov registry record
CIBMTR Research Database
A clinical trial of Solid Tumors and Allogeneic Stem Cell Transplantation, sponsored by Center for International Blood and Marrow Transplant Research.
- Recruiting
- Registry status
- 2
- Study locations
NCT01166009: Recruiting study of Solid Tumors and Allogeneic Stem Cell Transplantation, sponsored by Center for International Blood and Marrow Transplant Research.
NCT01166009 is a study of Solid Tumors and Allogeneic Stem Cell Transplantation that is actively recruiting participants, run by Center for International Blood and Marrow Transplant Research. The registry lists this as an open-ended (no fixed target) study. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01166009, a study of Solid Tumors and Allogeneic Stem Cell Transplantation, is actively recruiting participants, sponsored by Center for International Blood and Marrow Transplant Research.
- RECRUITING
- Registry status
- open-ended (no fixed target)
- Enrollment target
- 2
- Study locations
Study Summary
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies. A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries. Objectives: To learn more about what makes stem cell transplants and cellular therapies work well such as: * Determine how well recipients recover from their transplants or cellular therapy; * Determine how recovery after a transplant or cellular therapy can be improved; * Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy; * Determine how access to transplant or cellular therapy for different groups of patients can be improved; * Determine how well donors recover from the collection procedures.
Primary Outcome
A primary outcome is to have a comprehensive source of stem cell transplant data that can be used to assess topics such as: * Recipient Recover time * How recovery after transplant and other cellular therapies can be improved * Long term outcomes after transplantation and other cellular therapies * How well donors recover from collection procedure
Conditions Studied
Study Locations (2)
Minnesota
- Center for International Blood and Marrow Transplant Research - Minneapolis
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | open-ended (no fixed target) |
| Start Date | 2002-07 |
| Est. Completion | 2050-07 |
What NCT01166009 shows while recruiting
NCT01166009 is an observational study that tracks outcomes without assigning an intervention. The registry lists this as an open-ended (no fixed target) study, common for long-running registries that collect data indefinitely.
The record links to 7 conditions, with Solid Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT01166009 reports a single indexed study location in Minnesota, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01166009 about?
NCT01166009 is a clinical study titled "CIBMTR Research Database". The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies. A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries. Objectiv...
What is the current status of trial NCT01166009?
This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 2002-07. Estimated completion is 2050-07.
What conditions does trial NCT01166009 study?
This clinical trial studies the following conditions: Solid Tumors, Allogeneic Stem Cell Transplantation, Blood Cancers, Autologous Stem Cell Transplantation, Gene Therapy.
Who is sponsoring clinical trial NCT01166009?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01166009 being conducted?
This trial has 2 study locations across Minnesota, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
RECRUITING · Phase 4
-
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of INCB123667 in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
-
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia